blog

Watch the first of a series of podcasts highlighting the personal experiences of people with substance abuse disorders.

Ethnobridging studies support the launching of global Phase II/III clinical development programs in countries such as Japan.

Clinical studies involving pediatric or geriatric subjects, patients with particular physical limitations, as well as some preclinical studies, are excellent candidates for a microsampling approach.

Hallucinogens, dissociatives and other Schedule I drugs are increasingly being found to have a clinical application in a number of therapeutic areas. Recent approvals, background, and related case studies in this month's blog.